Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents
Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investiga...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
1996 |
|---|
| Umfang: |
5 Ill. ; 2 Tab. 9 |
|---|
| Reproduktion: |
Wiley InterScience Backfile Collection 1832-2000 |
|---|---|
| Übergeordnetes Werk: |
in: Biotechnology and Bioengineering - New York, NY [u.a.] : Wiley, 49(1996) vom: Mai, Seite 535-543 |
| Übergeordnetes Werk: |
volume:49 ; year:1996 ; month:05 ; pages:535-543 ; extent:9 |
| Links: |
|---|
| Katalog-ID: |
NLEJ159665329 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ159665329 | ||
| 003 | DE-627 | ||
| 005 | 20230505213008.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 070201s1996 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)NLEJ159665329 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents |
| 264 | 1 | |c 1996 | |
| 300 | |b 5 Ill. |b 2 Tab. | ||
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc. | ||
| 533 | |f Wiley InterScience Backfile Collection 1832-2000 | ||
| 700 | 1 | |a Green, K. D. |4 oth | |
| 700 | 1 | |a Gill, I. S. |4 oth | |
| 700 | 1 | |a Khan, J. A. |4 oth | |
| 700 | 1 | |a Vulfson, E. N. |4 oth | |
| 773 | 0 | 8 | |i in |t Biotechnology and Bioengineering |d New York, NY [u.a.] : Wiley |g 49(1996) vom: Mai, Seite 535-543 |w (DE-627)NLEJ159070678 |w (DE-600)1480809-2 |x 0006-3592 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:1996 |g month:05 |g pages:535-543 |g extent:9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO;2-K |q text/html |z Deutschlandweit zugänglich |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-WIS | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 1996 |c 5 |h 535-543 |g 9 | ||
| matchkey_str |
article:00063592:1996----::irecpuainfesclsntersaaictls |
|---|---|
| hierarchy_sort_str |
1996 |
| publishDate |
1996 |
| allfields |
(DE-627)NLEJ159665329 DE-627 ger DE-627 rakwb eng Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents 1996 5 Ill. 2 Tab. 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc. Wiley InterScience Backfile Collection 1832-2000 Green, K. D. oth Gill, I. S. oth Khan, J. A. oth Vulfson, E. N. oth in Biotechnology and Bioengineering New York, NY [u.a.] : Wiley 49(1996) vom: Mai, Seite 535-543 (DE-627)NLEJ159070678 (DE-600)1480809-2 0006-3592 nnns volume:49 year:1996 month:05 pages:535-543 extent:9 http://dx.doi.org/10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO;2-K text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-WIS GBV_NL_ARTICLE AR 49 1996 5 535-543 9 |
| spelling |
(DE-627)NLEJ159665329 DE-627 ger DE-627 rakwb eng Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents 1996 5 Ill. 2 Tab. 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc. Wiley InterScience Backfile Collection 1832-2000 Green, K. D. oth Gill, I. S. oth Khan, J. A. oth Vulfson, E. N. oth in Biotechnology and Bioengineering New York, NY [u.a.] : Wiley 49(1996) vom: Mai, Seite 535-543 (DE-627)NLEJ159070678 (DE-600)1480809-2 0006-3592 nnns volume:49 year:1996 month:05 pages:535-543 extent:9 http://dx.doi.org/10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO;2-K text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-WIS GBV_NL_ARTICLE AR 49 1996 5 535-543 9 |
| allfields_unstemmed |
(DE-627)NLEJ159665329 DE-627 ger DE-627 rakwb eng Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents 1996 5 Ill. 2 Tab. 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc. Wiley InterScience Backfile Collection 1832-2000 Green, K. D. oth Gill, I. S. oth Khan, J. A. oth Vulfson, E. N. oth in Biotechnology and Bioengineering New York, NY [u.a.] : Wiley 49(1996) vom: Mai, Seite 535-543 (DE-627)NLEJ159070678 (DE-600)1480809-2 0006-3592 nnns volume:49 year:1996 month:05 pages:535-543 extent:9 http://dx.doi.org/10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO;2-K text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-WIS GBV_NL_ARTICLE AR 49 1996 5 535-543 9 |
| allfieldsGer |
(DE-627)NLEJ159665329 DE-627 ger DE-627 rakwb eng Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents 1996 5 Ill. 2 Tab. 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc. Wiley InterScience Backfile Collection 1832-2000 Green, K. D. oth Gill, I. S. oth Khan, J. A. oth Vulfson, E. N. oth in Biotechnology and Bioengineering New York, NY [u.a.] : Wiley 49(1996) vom: Mai, Seite 535-543 (DE-627)NLEJ159070678 (DE-600)1480809-2 0006-3592 nnns volume:49 year:1996 month:05 pages:535-543 extent:9 http://dx.doi.org/10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO;2-K text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-WIS GBV_NL_ARTICLE AR 49 1996 5 535-543 9 |
| allfieldsSound |
(DE-627)NLEJ159665329 DE-627 ger DE-627 rakwb eng Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents 1996 5 Ill. 2 Tab. 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc. Wiley InterScience Backfile Collection 1832-2000 Green, K. D. oth Gill, I. S. oth Khan, J. A. oth Vulfson, E. N. oth in Biotechnology and Bioengineering New York, NY [u.a.] : Wiley 49(1996) vom: Mai, Seite 535-543 (DE-627)NLEJ159070678 (DE-600)1480809-2 0006-3592 nnns volume:49 year:1996 month:05 pages:535-543 extent:9 http://dx.doi.org/10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO;2-K text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-WIS GBV_NL_ARTICLE AR 49 1996 5 535-543 9 |
| language |
English |
| source |
in Biotechnology and Bioengineering 49(1996) vom: Mai, Seite 535-543 volume:49 year:1996 month:05 pages:535-543 extent:9 |
| sourceStr |
in Biotechnology and Bioengineering 49(1996) vom: Mai, Seite 535-543 volume:49 year:1996 month:05 pages:535-543 extent:9 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
Biotechnology and Bioengineering |
| authorswithroles_txt_mv |
Green, K. D. @@oth@@ Gill, I. S. @@oth@@ Khan, J. A. @@oth@@ Vulfson, E. N. @@oth@@ |
| publishDateDaySort_date |
1996-05-01T00:00:00Z |
| hierarchy_top_id |
NLEJ159070678 |
| id |
NLEJ159665329 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ159665329</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505213008.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070201s1996 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ159665329</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="b">5 Ill.</subfield><subfield code="b">2 Tab.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Wiley InterScience Backfile Collection 1832-2000</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Green, K. D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gill, I. S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Khan, J. A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vulfson, E. N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Biotechnology and Bioengineering</subfield><subfield code="d">New York, NY [u.a.] : Wiley</subfield><subfield code="g">49(1996) vom: Mai, Seite 535-543</subfield><subfield code="w">(DE-627)NLEJ159070678</subfield><subfield code="w">(DE-600)1480809-2</subfield><subfield code="x">0006-3592</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:49</subfield><subfield code="g">year:1996</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:535-543</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO;2-K</subfield><subfield code="q">text/html</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-WIS</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">49</subfield><subfield code="j">1996</subfield><subfield code="c">5</subfield><subfield code="h">535-543</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| series2 |
Wiley InterScience Backfile Collection 1832-2000 |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ159070678 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| collection |
NL |
| remote_str |
true |
| illustrated |
Illustrated |
| issn |
0006-3592 |
| topic_title |
Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
k d g kd kdg i s g is isg j a k ja jak e n v en env |
| hierarchy_parent_title |
Biotechnology and Bioengineering |
| hierarchy_parent_id |
NLEJ159070678 |
| hierarchy_top_title |
Biotechnology and Bioengineering |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ159070678 (DE-600)1480809-2 |
| title |
Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents |
| spellingShingle |
Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents |
| ctrlnum |
(DE-627)NLEJ159665329 |
| title_full |
Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents |
| journal |
Biotechnology and Bioengineering |
| journalStr |
Biotechnology and Bioengineering |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1996 |
| contenttype_str_mv |
zzz |
| container_start_page |
535 |
| container_volume |
49 |
| physical |
5 Ill. 2 Tab. 9 |
| format_se |
Elektronische Aufsätze |
| title_sort |
microencapsulation of yeast cells and their use as a biocatalyst in organic solvents |
| title_auth |
Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents |
| abstract |
Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc. |
| abstractGer |
Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc. |
| abstract_unstemmed |
Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc. |
| collection_details |
GBV_USEFLAG_U ZDB-1-WIS GBV_NL_ARTICLE |
| title_short |
Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents |
| url |
http://dx.doi.org/10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO;2-K |
| remote_bool |
true |
| author2 |
Green, K. D. Gill, I. S. Khan, J. A. Vulfson, E. N. |
| author2Str |
Green, K. D. Gill, I. S. Khan, J. A. Vulfson, E. N. |
| ppnlink |
NLEJ159070678 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| up_date |
2024-07-05T22:19:24.772Z |
| _version_ |
1803779272629813248 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ159665329</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505213008.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070201s1996 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ159665329</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="b">5 Ill.</subfield><subfield code="b">2 Tab.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Stable, semipermeable polyamide microcapsules were prepared by interfacial polymerization from a mixture of 1,6-hexanediamine and poly(allylamine) crosslinked with di-acid chlorides and were used to encapsulate baker's yeast. The size and distribution of cells within the capsules were investigated by a combination of laser confocal, electron scanning, and transmission electron microscopy. The encapsulated cells were studied as a biocatalyst for the model reduction of 1-phenyl-1,2-propanedione to 2-hydroxy-1-phenyl-1-propanone in a number of organic solvents. The polymerization conditions were extensively investigated and were found to greatly influence the product yield. Microencapsulated yeast cells, prepared under optimized conditions, carried out the reduction more efficiently than free cells as well as those immobilized in alginate and κ-carrageenan beads. The developed methodology should be broadly applicable to other biotransformations of interest. © 1996 John Wiley & Sons, Inc.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Wiley InterScience Backfile Collection 1832-2000</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Green, K. D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gill, I. S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Khan, J. A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vulfson, E. N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Biotechnology and Bioengineering</subfield><subfield code="d">New York, NY [u.a.] : Wiley</subfield><subfield code="g">49(1996) vom: Mai, Seite 535-543</subfield><subfield code="w">(DE-627)NLEJ159070678</subfield><subfield code="w">(DE-600)1480809-2</subfield><subfield code="x">0006-3592</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:49</subfield><subfield code="g">year:1996</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:535-543</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO;2-K</subfield><subfield code="q">text/html</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-WIS</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">49</subfield><subfield code="j">1996</subfield><subfield code="c">5</subfield><subfield code="h">535-543</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| score |
7.399496 |